PACCE Results: Poorer Outcomes When Panitumumab is Added to Chemotherapy and Avastin

Patients being treated for the first time with chemotherapy and Avastin® (bevacizumab) do worse if Vectibix™ (panitumumab) is added to their chemotherapy.  Median time until the cancer progresses is shorter, and they have more serious side effects. KRAS status made…  Read More

Preventive Measures Reduce Rash from Vectibix

Nearly all patients who are treated with Vectibix™ (panitumumab) will develop an itchy skin rash that looks something like acne.  However, treating the rash preemptively  before it appears reduces its severity and lengthens the time before more serious rash appears.…  Read More

Is KRAS Testing Right for You?

Concerned about whether you should have your tumor tested for a KRAS mutation? You should discuss KRAS testing and your treatment options with your doctor If you are currently being treated with Erbitux® (cetuximab) or Vectibix™ (panitumumab) for colorectal cancer.…  Read More